Skip to main content
. 2023 Nov 8;8(21):e170521. doi: 10.1172/jci.insight.170521

Figure 3. Knockdown of CNN2 attenuates tubular cell death and kidney inflammation in AKI.

Figure 3

(A and B) Representative micrographs (A) and quantitative data (B) of TUNEL staining in ShNC and ShCNN2 mouse kidneys 1 day after IRI or 3 days after cisplatin injection. Arrows indicate apoptotic cells. DAPI is a nuclear counterstain. Scale bar, 50 µm. *P < 0.05 (n = 5). (C) Western blot assay demonstrated the expression of AIF, FADD, Bax, and ARC in ShNC and ShCNN2 mouse kidneys at 1 day after IRI (n = 6). (D) Western blot assay demonstrated p-MLKL, MLKL, and GPX4 expression in ShNC and ShCNN2 mouse kidneys at 1 day after IRI. (E) Representative immunohistochemical staining micrographs for p-MLKL, GPX4, CD45, Ki67, and PCNA in ShNC and ShCNN2 mouse kidneys 1 day after IRI or 3 days after cisplatin injection. Scale bar, 50 µm. Arrows indicate positive staining. (F) Quantitative real-time PCR analyses revealed the mRNA abundance of Rantes, IL-6, and TNF-α in ShNC and ShCNN2 mouse kidneys 1 day after IRI or 3 days after cisplatin injection. *P < 0.05 (n = 6). (G) Immunofluorescence staining showed F4/80+ macrophages in ShNC and ShCNN2 mouse kidneys 1 day after IRI. Scale bar, 50 µm. Arrows indicate positive staining. (H) Western blot assays demonstrated PCNA expression in ShNC and ShCNN2 mouse kidneys at 1 day after IRI or 3 days after cisplatin injection. (I) Western blot assays demonstrated PDGFR-β and α-SMA expression in the kidneys from ShNC and ShCNN2 mice 1 day after IRI. For all Western blot panels, numbers indicate individual animals within each group. Graphs are presented as means ± SEM. Differences between groups were analyzed using unpaired t tests or ANOVA followed by the Student-Newman-Keuls test. AIF, apoptosis inducing factor; ARC, apoptosis repressor with caspase recruitment domain; FADD, Fas-associated protein with death domain; p-MLKL, phosphorylated mixed lineage kinase domain-like protein; GPX4, glutathione peroxidase 4; α-SMA, α–smooth muscle actin.